Examining blood vessel health in obese adults with insulin resistance using Vitamin C
Official title: Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance
Run by University of Kansas Medical Center · NCT04715022 · Data updated 2026-11-12
This study is testing if Vitamin C can help improve blood vessel health and lower blood pressure in obese adults with insulin resistance.
Quick facts
| Phase | Phase1; Phase2 |
|---|---|
| Study type | Interventional |
| Ages | 35 Years to 65 Years |
| Sex | All |
| Enrollment | 23 (estimated) |
| Sponsor | University of Kansas Medical Center Academic / other |
| Locations | 1 site (Kansas City, Kansas) |
| Status | Recruiting |
| Started | June 17, 2021 |
| Main results expected | August 1, 2026 |
| Study ends | August 1, 2027 |
| Registry record updated | June 8, 2025 |
| Trial ID | NCT04715022 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are obese adults aged 35-65 with insulin resistance who are not currently taking certain supplements or medications.
✕Probably not a fit
Patients with diabetes, controlled hypertension, or a history of heart or vascular disease may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates how obesity and insulin resistance contribute to hypertension and cardiovascular diseases by examining blood vessel health and nerve activity in affected adults. It specifically tests the effects of ascorbic acid (Vitamin C) on improving blood vessel function and lowering blood pressure. Participants will be monitored for changes in blood pressure as a primary outcome, with the goal of identifying mechanisms to reduce vascular dysfunction. The study aims to provide insights that could lead to targeted interventions for hypertension in this population.
Why it matters
Potential benefit: If successful, this study could lead to new treatments for hypertension in obese individuals with insulin resistance.
How similar studies have gone: Other studies have shown promising results in using Vitamin C for vascular health, but this specific approach in the context of obesity and insulin resistance is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Obese: BMI \>30 m/kg2 2. Middle-aged: 35-65 years 3. Participants must be willing and able to discontinue taking any vitamin C or E supplements or omega-3 fatty acids beginning 2 weeks prior. 4. Able and willing to provide written informed consent Exclusion Criteria: 1. Diabetes mellitus: fasting glucose \< 1267 mg/dL and/or HbA1c \< 6.5% 2. Currently taking a statin or antihypertension medication 3. Hyperlipidemia: Fasting triglycerides \< 250 mg/dL 4. Hypertension: \<130/80 mmHg 5. History of heart disease (e.g., myocardial infarction, stent) 6. History of vascular disease (e.g., bypass, stroke)
Where it's running
-
University of Kansas Medical Center
Kansas City, Kansas, United States Recruiting
Study contacts
- Principal investigator: Seth Holwerda, PhD — University of Kansas Medical Center
- Study coordinator: Seth Holwerda, PhD
- Email: sholwerda@kumc.edu
- Phone: 9729223230
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using low-dose aspirin after preeclampsia to improve recovery
This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.
-
Rural Telemedicine-Enabled Care to Prevent Stroke in Older Adults in China
A telemedicine-supported care model led by rural doctors will be tested to see if it can reduce stroke and heart problems in adults 65+ living in rural China.
-
Home-based cardiovascular health screening for people turning 50, 55, 60, 65, 70 or 75 in Uppsala
This trial tests whether giving people a home blood pressure monitor, a dried blood spot kit, and a questionnaire can find more cardiovascular risk factors than usual care.
-
RADIANCE CED: long-term outcomes after ultrasound renal denervation
This project will see if ultrasound renal denervation (using the Paradise system) lowers blood pressure over the long term in Medicare-age adults (65+) with uncontrolled hypertension by using their medical records.
-
Pulmonary Artery Denervation for a specific type of heart and lung pressure problem
This study tests whether the Enhancor System can safely and effectively help patients with combined pre- and post-capillary pulmonary hypertension due to left heart disease when added to standard therapy.
-
Postpartum program to prevent cardiometabolic problems after preeclampsia
This study will test a 9-month app-based support program to lower blood pressure and help with weight loss in first-time mothers who recently had preeclampsia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.